News

Max on the wall

Murals create opportunities for bold, highly visible statements. Over the last few decades street art has come a long way from an act of rebellion to…

Read more

Awards of the Vienna BioCenter PhD Symposium 2022

Eight students at the Vienna BioCenter were recognized for their outstanding doctoral research during this year’s Vienna BioCenter PhD Symposium. From…

Read more

HUSHing repetitive-like elements contributes to normal brain development and function

The gene-silencing complex HUSH might be involved in complex disorders affecting the brain and neurons. However, its mechanism of action remains…

Read more

APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01

APEIRON Respiratory Therapies announced positive final results from a Phase I clinical trial of inhaled APN01 (alunacedase alfa), a soluble…

Read more
Roland Foisner, Martin Leeb, Thomas Leonard (c) Max Perutz Labs

FWF grants awarded to Max Perutz Labs scientists

Congratulations to group leaders Roland Foisner, Martin Leeb, and Thomas Leonard who have received funding from the Austrian Science Fund FWF…

Read more

invIOs to present data from clinical stage Cbl-b program at SITC 2022

invIOs announced that two abstracts on its clinical stage lead program, APN401, have been accepted for poster presentations at the 37th Annual Meeting…

Read more

New stop along the cellular journey of recycling organelles in plants

A “hub and spoke” system enables plant cells to efficiently coordinate cellular trafficking, particularly for cellular recycling, the so-called…

Read more

Old drugs new tricks

Group leader Jörg Menche is part of Repo4EU, a platform for mechanism-based drug repurposing. The consortium, which includes 28 partners from 10…

Read more

Oncogenic virus: Scientists show how HPV causes skin cancer

Viruses are thought to play a role in the development of about 10 percent of human cancers. An international research team led by scientists in Vienna…

Read more

Genomics and artificial intelligence to empower cancer diagnostics

The lab of Anna Obenauf at the IMP just published their findings: the human papillomavirus HPV42 causes Digital Papillary Adenocarcinoma. Within the…

Read more

Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate at Leading Scientific Conferences

Valneva announced it will present on its single-shot chikungunya vaccine candidate at several leading scientific conferences during the fourth quarter…

Read more

Rabitsch Award 2022 for Melanie de Almeida

Established in 2006, the Kirsten Peter Rabitsch Award is presented annually in recognition of outstanding achievements to a PhD student at the IMP or…

Read more